Being un‐affected men with a pathogenic or pathogenic‐like germline variant in a DRG is associated with a higher risk of PCa, especially among BRCA2 mutation carriers (OR = 2.64, 95%CI:2.03–3.47), and is also associated with poorer cancer‐specific (CSS; HR = 2.53, 95%CI:1.98–3.22) and overall survival rates (HR 2.08, 95%CI:1.55–2.79).17 The gene discussed is BRCA2; the disease is cancer.